◼ Archived
Business
Xenon Stock Craters 30% on Drug Trial Setback. Its Failure Could Be This Biotech’s Gain.
0sources
0articles
0velocity
59d agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (0)
Related trends
▲ Peaking
Business
AMD and Google Chip Away at Nvidia as Huang Exit Shakes Customers
▲ Peaking
Business
Nike targets 2029 sales growth in effort to reassure wary investors
▲ Peaking
Business
OpenAI’s New Hacking Model Found Dozens Of Holes In Apple Tech
▲ Peaking
Business
Some of the world’s most-visited websites targeted by cyberattack - WBAL-TV
▲ Peaking
Business
Kalshi halts trading on Trump's speeches
↑ Rising
Business